8 Results for "

Gliclazide

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Gliclazide" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-B0753
CAS No.: 21187-98-4
Synonyms: S1702; SE1702
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic .
loading...
    loading...
Cat. No.: HY-P10303
CAS No.: 2767993-86-0
Synonyms: Cyclo[RGDfK(Azide)]
Research Areas:  

Others

Cyclo[Arg-Gly-Asp-D-Phe-Lys(Azide)] (Cyclo[RGDfK(Azide)]) is a derivative of Cyclo (-RGDfK) (HY-P0023). Cyclo[Arg-Gly-Asp-D-Phe-Lys (Azide)] is a click chemistry reagent containing an azide group. Cyclo[Arg-Gly-Asp-D-Phe-Lys (Azide)] enables functionalization of alginate via SPAAC bioconjugation. Alginate hydrogels functionalized with Cyclo[Arg-Gly-Asp-D-Phe-Lys (Azide)] significantly promote cell expansion while maintaining cell pluripotency .
loading...
    loading...
Cat. No.: HY-B0753R
CAS No.: 21187-98-4
Synonyms: S1702 (Standard); SE1702 (Standard)
Gliclazide (Standard) is the analytical standard of Gliclazide. This product is intended for research and analytical applications. Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic .
loading...
    loading...
Cat. No.: HY-B0753S
CAS No.: 1185039-30-8
Gliclazide-d4 (S1702 D4) is the deuterium labeled Gliclazide. Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic .
loading...
    loading...
Cat. No.: HY-132617S
CAS No.: 1346602-90-1
Carboxy Gliclazide-d4 is the deuterium labeled Carboxy Gliclazide .
loading...
    loading...
Cat. No.: HY-135337
CAS No.: 5577-13-9
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Ethyl tosylcarbamate is an intermediate in the synthesis of Gliclazide (G409877) . Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM .
loading...
    loading...
Cat. No.: HY-W723322
Ethyl tosylcarbamate-d7 is the deuterium labeled Ethyl tosylcarbamate (HY-135337). Ethyl tosylcarbamate is an intermediate in the synthesis of Gliclazide (G409877) . Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM .
loading...
    loading...
Cat. No.: HY-180784
Hypoglycemic agent 4 (Compound 5b) is a tetrahydroacridine derivative with orally active hypoglycemic activity. Hypoglycemic agent 4 has a good binding affinity for the key diabetic targets: DPP-IV, SGLT1, and GLUT2. Hypoglycemic agent 4 can inhibit glucose diffusion. Hypoglycemic agent 4 can reduce fasting blood sugar in Streptozotocin (HY-13753)-induced diabetic rats and its effect is comparable to Gliclazide (HY-B0753). Hypoglycemic agent 4 can be used for research of type 2 diabetes .
loading...
    loading...